RAD51 expression in breast tumors was positively correlated with E2F1 expression and negatively correlated with TODRA (Table 1), indicating that E2F1 indeed regulates the bidirectional promoter in vivo in the malignant state, in the same manner we observed in cell lines. The gene discussed is E2F1; the disease is breast neoplasm.